Inventor · disambiguated record
Iain Watson
Also filed as: WATSON IAIN
2 granted patents·3 pending applications·3 citations·filing 2018–2022
36Inventor score
Files withONTARIO INSTITUTE FOR CANCER RES OICR5
Top patents by PatentIndex Score
5 records- 0180US11518764B2Substituted heteroaryls as inhibitors of the BCL6 BTB domain protein-protein interactionONTARIO INSTITUTE FOR CANCER RES OICR·Filed 2019·Granted Dec 6, 2022·3 cites·18 claims
- 0256US2024343704A1Halo-substituted amino pyridine compounds as inhibitors of the haematopoietic progenitor kinase 1 (hpk1)ONTARIO INSTITUTE FOR CANCER RES OICR·Filed 2022·Application pending·0 cites
- 0355US2024425479A1Halo-substituted amino aza-heteroaryl compounds as inhibitors of the haematopoietic progenitor kinase 1 (hpk1)ONTARIO INSTITUTE FOR CANCER RES OICR·Filed 2022·Application pending·0 cites
- 0454US2024317723A1Substituted amino aza-heteroaryl compounds as inhibitors of the haematopoietic progenitor kinase 1 (hpk1)ONTARIO INSTITUTE FOR CANCER RES OICR·Filed 2022·Application pending·0 cites
- 0542US11242351B2Tricyclic inhibitors of the BCL6 BTB domain protein-protein interaction and uses thereofONTARIO INSTITUTE FOR CANCER RES OICR·Filed 2018·Granted Feb 8, 2022·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Iain Watson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →